about
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Constr...
Read More
35.68
-0.43
(-1.19%)
38,407.4
XNAS Volume
XNAS 23 Jul, 2026 1:48 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Neurogene Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..